Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
The Value of Digital Biomarkers in Clinical Trials
Blog Posts
Series: Ask the IRB & IBC Experts
What Is the Accelerated Approval Pathway? Understanding the Latest FDA Guidance
Blog Posts
Review of the FDA Draft Guidance: Considerations for Including Tissue Biopsies in Clinical Trials
Blog Posts
Unlocking the Potential of RBANS in Predicting Alzheimer’s Disease Progression
Blog Posts
Scoring Discrepancies in MDS-UPDRS Part III in Parkinson’s Disease Clinical Trials: Insights from Independent Review
Blog Posts
Artificial Intelligence and Machine Learning in Clinical Trials
Advancing Clinical Trials with AI
Blog Posts
Leveraging Standardized Data to Streamline Site Feasibility
Blog Posts
Ethics in Clinical Research
The FDA’s Guidance on Electronic Records and Signatures: Key Takeaways
Blog Posts
Artificial Intelligence and Machine Learning in Clinical Trials
The Role of AI in Regulatory Decision-Making for Drugs & Biologics: the FDA’s Latest Guidance
Blog Posts